Hydrops fetalis–associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation

Hydrops fetalis is rarely caused by congenital dyserythropoietic anemia (CDA). We report a patient with hydrops fetalis as a result of severe anemia. This patient needed intrauterine transfusions from 21 weeks of gestation until birth. The hematologic study showed an atypical CDA (hydrops fetalis–as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2002-07, Vol.100 (1), p.356-358
Hauptverfasser: Remacha, Angel F., Badell, Isabel, Pujol-Moix, Núria, Parra, Juan, Muñiz-Diaz, Eduardo, Ginovart, Gemma, Sardà, M. Pilar, Hernández, Angel, Moliner, Elisenda, Torrent, Montserrat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 358
container_issue 1
container_start_page 356
container_title Blood
container_volume 100
creator Remacha, Angel F.
Badell, Isabel
Pujol-Moix, Núria
Parra, Juan
Muñiz-Diaz, Eduardo
Ginovart, Gemma
Sardà, M. Pilar
Hernández, Angel
Moliner, Elisenda
Torrent, Montserrat
description Hydrops fetalis is rarely caused by congenital dyserythropoietic anemia (CDA). We report a patient with hydrops fetalis as a result of severe anemia. This patient needed intrauterine transfusions from 21 weeks of gestation until birth. The hematologic study showed an atypical CDA (hydrops fetalis–associated CDA) characterized by features resembling CDA type II, but negative acidified serum lysis test (HEMPAS negative). The patient was regularly transfused for a year, after which an allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling was successfully carried out. His actual hemoglobin is 127 g/L, and he has not received transfusions for more than a year. In conclusion, intrauterine transfusions and BMT could cure an otherwise lethal atypical CDA.
doi_str_mv 10.1182/blood-2001-12-0351
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71830265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120600155</els_id><sourcerecordid>71830265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-133237eb9da92623b91c9b53f21d85ee1dfba47328b96b40b751db0cd130e11c3</originalsourceid><addsrcrecordid>eNp9kE1rFEEQhhtRzCb6BzzIXPQ22lU9n-BFgiZCwIuem_6oMS2z02tXj2Fv3vwB_kN_ib3Zhdw8FdT7VPHyCPEC5BuAAd_aOUZfo5RQA9ZStfBIbKDFoZYS5WOxkVJ2dTP2cCbOmb8XsFHYPhVngLKXsoWN-H299ynuuJoomznw319_DHN0wWTylYvLN1pCSSq_Z0r7fFvgGCgHV5mFtsFUOdE9exfybRWWnMyaKYWFSmIWnlYOceFC-8rGst2alOLdMdzNZskmF-CZeDKZmen5aV6Irx8_fLm8rm8-X326fH9Tuwa7XINSqHqyozcjdqjsCG60rZoQ_NASgZ-saXqFgx0720jbt-CtdB6UJACnLsTr499dij9W4qy3gR3NpQjFlXUPg5LYtQXEI-hSZE406V0Kpfteg9QH_fpevz7o14D6oL8cvTx9X-2W_MPJyXcBXp0Aw87MU5HgAj9wqm8RGyzcuyNHxcXPQEmzC7Q48iGRy9rH8L8e_wBA16hs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71830265</pqid></control><display><type>article</type><title>Hydrops fetalis–associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Remacha, Angel F. ; Badell, Isabel ; Pujol-Moix, Núria ; Parra, Juan ; Muñiz-Diaz, Eduardo ; Ginovart, Gemma ; Sardà, M. Pilar ; Hernández, Angel ; Moliner, Elisenda ; Torrent, Montserrat</creator><creatorcontrib>Remacha, Angel F. ; Badell, Isabel ; Pujol-Moix, Núria ; Parra, Juan ; Muñiz-Diaz, Eduardo ; Ginovart, Gemma ; Sardà, M. Pilar ; Hernández, Angel ; Moliner, Elisenda ; Torrent, Montserrat</creatorcontrib><description>Hydrops fetalis is rarely caused by congenital dyserythropoietic anemia (CDA). We report a patient with hydrops fetalis as a result of severe anemia. This patient needed intrauterine transfusions from 21 weeks of gestation until birth. The hematologic study showed an atypical CDA (hydrops fetalis–associated CDA) characterized by features resembling CDA type II, but negative acidified serum lysis test (HEMPAS negative). The patient was regularly transfused for a year, after which an allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling was successfully carried out. His actual hemoglobin is 127 g/L, and he has not received transfusions for more than a year. In conclusion, intrauterine transfusions and BMT could cure an otherwise lethal atypical CDA.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2001-12-0351</identifier><identifier>PMID: 12070051</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Adult ; Anemia, Dyserythropoietic, Congenital - complications ; Anemia, Dyserythropoietic, Congenital - therapy ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Transfusion, Intrauterine ; Bone Marrow Transplantation ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Diseases of mother, fetus and pregnancy ; Family Health ; Female ; Fetal Diseases - therapy ; Gynecology. Andrology. Obstetrics ; Humans ; Hydrops Fetalis - diagnosis ; Hydrops Fetalis - etiology ; Hydrops Fetalis - therapy ; Infant, Newborn ; Male ; Medical sciences ; Pregnancy ; Pregnancy. Fetus. Placenta ; Prenatal Diagnosis ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Transplantation, Homologous ; Treatment Outcome</subject><ispartof>Blood, 2002-07, Vol.100 (1), p.356-358</ispartof><rights>2002 American Society of Hematology</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-133237eb9da92623b91c9b53f21d85ee1dfba47328b96b40b751db0cd130e11c3</citedby><cites>FETCH-LOGICAL-c426t-133237eb9da92623b91c9b53f21d85ee1dfba47328b96b40b751db0cd130e11c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13752242$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12070051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Remacha, Angel F.</creatorcontrib><creatorcontrib>Badell, Isabel</creatorcontrib><creatorcontrib>Pujol-Moix, Núria</creatorcontrib><creatorcontrib>Parra, Juan</creatorcontrib><creatorcontrib>Muñiz-Diaz, Eduardo</creatorcontrib><creatorcontrib>Ginovart, Gemma</creatorcontrib><creatorcontrib>Sardà, M. Pilar</creatorcontrib><creatorcontrib>Hernández, Angel</creatorcontrib><creatorcontrib>Moliner, Elisenda</creatorcontrib><creatorcontrib>Torrent, Montserrat</creatorcontrib><title>Hydrops fetalis–associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation</title><title>Blood</title><addtitle>Blood</addtitle><description>Hydrops fetalis is rarely caused by congenital dyserythropoietic anemia (CDA). We report a patient with hydrops fetalis as a result of severe anemia. This patient needed intrauterine transfusions from 21 weeks of gestation until birth. The hematologic study showed an atypical CDA (hydrops fetalis–associated CDA) characterized by features resembling CDA type II, but negative acidified serum lysis test (HEMPAS negative). The patient was regularly transfused for a year, after which an allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling was successfully carried out. His actual hemoglobin is 127 g/L, and he has not received transfusions for more than a year. In conclusion, intrauterine transfusions and BMT could cure an otherwise lethal atypical CDA.</description><subject>Adult</subject><subject>Anemia, Dyserythropoietic, Congenital - complications</subject><subject>Anemia, Dyserythropoietic, Congenital - therapy</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Transfusion, Intrauterine</subject><subject>Bone Marrow Transplantation</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Family Health</subject><subject>Female</subject><subject>Fetal Diseases - therapy</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Hydrops Fetalis - diagnosis</subject><subject>Hydrops Fetalis - etiology</subject><subject>Hydrops Fetalis - therapy</subject><subject>Infant, Newborn</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pregnancy</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Prenatal Diagnosis</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Transplantation, Homologous</subject><subject>Treatment Outcome</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rFEEQhhtRzCb6BzzIXPQ22lU9n-BFgiZCwIuem_6oMS2z02tXj2Fv3vwB_kN_ib3Zhdw8FdT7VPHyCPEC5BuAAd_aOUZfo5RQA9ZStfBIbKDFoZYS5WOxkVJ2dTP2cCbOmb8XsFHYPhVngLKXsoWN-H299ynuuJoomznw319_DHN0wWTylYvLN1pCSSq_Z0r7fFvgGCgHV5mFtsFUOdE9exfybRWWnMyaKYWFSmIWnlYOceFC-8rGst2alOLdMdzNZskmF-CZeDKZmen5aV6Irx8_fLm8rm8-X326fH9Tuwa7XINSqHqyozcjdqjsCG60rZoQ_NASgZ-saXqFgx0720jbt-CtdB6UJACnLsTr499dij9W4qy3gR3NpQjFlXUPg5LYtQXEI-hSZE406V0Kpfteg9QH_fpevz7o14D6oL8cvTx9X-2W_MPJyXcBXp0Aw87MU5HgAj9wqm8RGyzcuyNHxcXPQEmzC7Q48iGRy9rH8L8e_wBA16hs</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>Remacha, Angel F.</creator><creator>Badell, Isabel</creator><creator>Pujol-Moix, Núria</creator><creator>Parra, Juan</creator><creator>Muñiz-Diaz, Eduardo</creator><creator>Ginovart, Gemma</creator><creator>Sardà, M. Pilar</creator><creator>Hernández, Angel</creator><creator>Moliner, Elisenda</creator><creator>Torrent, Montserrat</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020701</creationdate><title>Hydrops fetalis–associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation</title><author>Remacha, Angel F. ; Badell, Isabel ; Pujol-Moix, Núria ; Parra, Juan ; Muñiz-Diaz, Eduardo ; Ginovart, Gemma ; Sardà, M. Pilar ; Hernández, Angel ; Moliner, Elisenda ; Torrent, Montserrat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-133237eb9da92623b91c9b53f21d85ee1dfba47328b96b40b751db0cd130e11c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Anemia, Dyserythropoietic, Congenital - complications</topic><topic>Anemia, Dyserythropoietic, Congenital - therapy</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Transfusion, Intrauterine</topic><topic>Bone Marrow Transplantation</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Family Health</topic><topic>Female</topic><topic>Fetal Diseases - therapy</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Hydrops Fetalis - diagnosis</topic><topic>Hydrops Fetalis - etiology</topic><topic>Hydrops Fetalis - therapy</topic><topic>Infant, Newborn</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pregnancy</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Prenatal Diagnosis</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Transplantation, Homologous</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Remacha, Angel F.</creatorcontrib><creatorcontrib>Badell, Isabel</creatorcontrib><creatorcontrib>Pujol-Moix, Núria</creatorcontrib><creatorcontrib>Parra, Juan</creatorcontrib><creatorcontrib>Muñiz-Diaz, Eduardo</creatorcontrib><creatorcontrib>Ginovart, Gemma</creatorcontrib><creatorcontrib>Sardà, M. Pilar</creatorcontrib><creatorcontrib>Hernández, Angel</creatorcontrib><creatorcontrib>Moliner, Elisenda</creatorcontrib><creatorcontrib>Torrent, Montserrat</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Remacha, Angel F.</au><au>Badell, Isabel</au><au>Pujol-Moix, Núria</au><au>Parra, Juan</au><au>Muñiz-Diaz, Eduardo</au><au>Ginovart, Gemma</au><au>Sardà, M. Pilar</au><au>Hernández, Angel</au><au>Moliner, Elisenda</au><au>Torrent, Montserrat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hydrops fetalis–associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2002-07-01</date><risdate>2002</risdate><volume>100</volume><issue>1</issue><spage>356</spage><epage>358</epage><pages>356-358</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Hydrops fetalis is rarely caused by congenital dyserythropoietic anemia (CDA). We report a patient with hydrops fetalis as a result of severe anemia. This patient needed intrauterine transfusions from 21 weeks of gestation until birth. The hematologic study showed an atypical CDA (hydrops fetalis–associated CDA) characterized by features resembling CDA type II, but negative acidified serum lysis test (HEMPAS negative). The patient was regularly transfused for a year, after which an allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling was successfully carried out. His actual hemoglobin is 127 g/L, and he has not received transfusions for more than a year. In conclusion, intrauterine transfusions and BMT could cure an otherwise lethal atypical CDA.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>12070051</pmid><doi>10.1182/blood-2001-12-0351</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2002-07, Vol.100 (1), p.356-358
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_71830265
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Anemia, Dyserythropoietic, Congenital - complications
Anemia, Dyserythropoietic, Congenital - therapy
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Blood Transfusion, Intrauterine
Bone Marrow Transplantation
Bone marrow, stem cells transplantation. Graft versus host reaction
Diseases of mother, fetus and pregnancy
Family Health
Female
Fetal Diseases - therapy
Gynecology. Andrology. Obstetrics
Humans
Hydrops Fetalis - diagnosis
Hydrops Fetalis - etiology
Hydrops Fetalis - therapy
Infant, Newborn
Male
Medical sciences
Pregnancy
Pregnancy. Fetus. Placenta
Prenatal Diagnosis
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Transplantation, Homologous
Treatment Outcome
title Hydrops fetalis–associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A24%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hydrops%20fetalis%E2%80%93associated%20congenital%20dyserythropoietic%20anemia%20treated%20with%20intrauterine%20transfusions%20and%20bone%20marrow%20transplantation&rft.jtitle=Blood&rft.au=Remacha,%20Angel%20F.&rft.date=2002-07-01&rft.volume=100&rft.issue=1&rft.spage=356&rft.epage=358&rft.pages=356-358&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2001-12-0351&rft_dat=%3Cproquest_cross%3E71830265%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71830265&rft_id=info:pmid/12070051&rft_els_id=S0006497120600155&rfr_iscdi=true